At EASD 2018, The Pharma Letter spoke with Novo Nordisk’s (NOV: N) chief medical officer Stephen Gough and chief science officer Mads Krogsgaard Thomsen and abo 2 October 2018
With World Alzheimer’s Day fast approaching, drugmakers and patients around the world are raising awareness of the challenges faced, and the progress made, in c 20 September 2018
Before joining Boston University to study biomedical engineering and chemistry, Mass Innovation Labs founder Amrit Chaudhuri was the youngest paid researcher at 3 September 2018
Making patients the owners of and beneficiaries from their own data will be key to making blockchain technology deliver for healthcare as a whole, according to 22 August 2018
“The innovation and transformative potential that this pipeline hold really give us a lot of confidence that we are going to emerge as a strong player in the on 3 August 2018
UCB (Euronext: UCB) rose 1.3% on Thursday after it published financial results for the first half of 2018. The Belgian drugmaker, which specialises in immunolog 26 July 2018
For several years, pharma analysts have predicted varying degrees of impact from nascent blockchain technologies. While some anticipate wholesale revolution, ot 23 July 2018
Janssen has been on a good run of form recently.Its potentially-blockbuster depression therapy.esketamine.has been posting good trial results and their combinat 16 July 2018
In March 2018.Celgene announced its intention to co-develop and co-market bb2121, a CAR-T cell therapy for the treatment of relapsed multiple myeloma.In convers 11 July 2018
When Seattle Genetics announced it had bought exclusive global rights to an an exciting new antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132), sha 9 July 2018
Since it first received US approval for thyroid cancer in February 2015, excitement around Eisai’s Lenvima (lenvatinib mesylate) as one of the hottest propertie 4 July 2018
Pharma companies sometimes need to be aware of advances in wearable technology that threaten to take market share away from their medicines, but such devices ca 2 July 2018
Ipsen (Euronext: IPN) has been in oncology for a long time — since the 1980s in fact. It's one of the field's top 20 companies. But in a market that’s turbulent 15 June 2018
In an oral presentation to be given at the annual meeting of the European League Against Rheumatism (EULAR), US-based Celgene will present a post hoc analysis o 14 June 2018
Despite an inexorable rise in the global population of type 2 diabetics, linked to changing lifestyle choices, markets for insulin are becoming ever more compet 30 May 2018
Soaring obesity rates and the accompanying scourge of type II diabetes have done wonders for insulin kingpin Novo Nordisk’s bottom line over the last quarter-ce 23 May 2018
Belén Garijo has been the CEO of the Healthcare business of German life sciences firm Merck KGaA since 2015. Speaking to The Pharma Letter, she discusses her co 17 May 2018
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.